Related references
Note: Only part of the references are listed.Adherence to antiretroviral therapy and its determinants in children with HIV infection - Experience from Paediatric Centre of Excellence in HIV Care in North India
Anju Seth et al.
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2014)
Adherence to antiretroviral therapy among HIV infected children measured by caretaker report, medication return, and drug level in Dar Es Salaam, Tanzania
Frida William Mghamba et al.
BMC PEDIATRICS (2013)
Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial
Hoosen M. Coovadia et al.
LANCET (2012)
Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians
Kevin C. Brown et al.
PHARMACOGENOMICS (2012)
Adherence to antiretroviral therapy and its correlates among HIV-infected children at an HIV clinic in New Delhi
M. Bhattacharya et al.
ANNALS OF TROPICAL PAEDIATRICS (2011)
Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda
A. Bagenda et al.
ANNALS OF TROPICAL PAEDIATRICS (2011)
Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals
Alessandro Schipani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Factors influencing plasma nevirapine levels: a study in HIV-infected children on generic antiretroviral treatment in India
Soumya Swaminathan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Standard Measures are Inadequate to Monitor Pediatric Adherence in a Resource-Limited Setting
Alexandra D. Mueller et al.
AIDS AND BEHAVIOR (2011)
Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission
Charles S. Chasela et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Adherence to Antiretroviral Therapy in Pediatric Patients With Human Immunodeficiency Virus (HIV-1)
Gail Burack et al.
JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES (2010)
Supporting children to adhere to anti-retroviral therapy in urban Malawi: multi method insights
Ralf Weigel et al.
BMC PEDIATRICS (2009)
Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population
T. W. Mahungu et al.
HIV MEDICINE (2009)
Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study
Mary-Ann Davies et al.
BMC PEDIATRICS (2008)
Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in Cameroon
Charles Kouanfack et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Electronic measurement of adherence to pediatric antiretroviral therapy in South Africa
Alexandra D. Mueller et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children
Akihiko Saitoh et al.
AIDS (2007)
Adherence to antiretroviral therapy in children attending Mulago Hospital, Kampala
Nicolette Nabukeera-Barungi et al.
ANNALS OF TROPICAL PAEDIATRICS (2007)
Cytochrome P4502B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda
S. R. Penzak et al.
HIV MEDICINE (2007)
Practical and conceptual challenges in measuring antiretroviral adherence
Karina M. Berg et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Adherence to antiretroviral therapy in sub-Saharan Africa and North America - A meta-analysis
Edward J. Mills et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Drug therapy - Adherence to medication
L Osterberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Measuring adherence to treatment of paediatric HIV/AIDS
S Naar-King et al.
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2005)
Safety and Trough Concentrations of Nevirapine Prophylaxis Given Daily, Twice Weekly, or Weekly in Breast-Feeding Infants From Birth to 6 Months
Avinash K. Shetty et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2003)
Adherence is not a barrier to successful antiretroviral therapy in South Africa
C Orrell et al.
AIDS (2003)
Therapeutic drug monitoring - An aid to optimising response to antiretroviral drugs?
RE Aarnoutse et al.
DRUGS (2003)
Therapeutic drug monitoring of HIV-protease inhibitors to assess noncompliance
PWH Hugen et al.
THERAPEUTIC DRUG MONITORING (2002)
Limited sampling strategies for the estimation of the systemic exposure to the HIV-1 nonnucleoside reverse transcriptase inhibitor nevirapine
AI Veldkamp et al.
THERAPEUTIC DRUG MONITORING (2001)
Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors
PF Smith et al.
CLINICAL PHARMACOKINETICS (2001)
Share Paper
